Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease

NCT04745624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-02-03

No results posted yet for this study

Summary

To study the patient characteristics and outcomes associated with the real-world use of manual compression vs. vascular closure devices (VCDs) after common femoral artery (CFA) percutaneous access for coronary and endovascular interventions. An institutional procedural database, based on electronic medical record information will be abstracted to collect this information.

Conditions

  • Common Femoral Artery Stenosis

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Carlos Mena-Hurtado, MD · Yale University

  • Kim Smolderen · Yale University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-20
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04745624 on ClinicalTrials.gov